India Genomics Market Overview, 2030

The genomics environment in India has changed dramatically, largely due to the Human Genome Mapping Project of India, which established the groundwork for extensive genomic research in the nation. As a result of this historic move, India was able to use genomics to tackle some of its most urgent healthcare issues. Two important areas where genomics is demonstrating its potential for revolutionizing care are cancer therapy and the identification of uncommon illnesses. The genetic variations responsible for uncommon diseases that are common among Indians are actively being identified by initiatives like GUaRDIAN (Genomics for Understanding Rare Diseases: India Alliance Network), which is led by CSIR. In a similar vein, cancer genomics programs are advancing the creation of individualized treatment regimens based on genomics. One of the first challenges India encountered was the absence of affordable genomic diagnostic services, which made advanced testing mostly unavailable to the majority of the public. The expansion of local businesses and innovation centers that concentrate on affordable genomics solutions is, however, altering this situation. Businesses like Mapmygenome, MedGenome, and Strand Life Sciences have made genomics-based health evaluations, cancer screening, and uncommon disease diagnosis more accessible at cheaper prices than international options. The lack of qualified individuals with training in clinical genetics, genomic data analysis, and bioinformatics remains a persistent issue despite this progress. The growing complexity of genomic research necessitates a highly skilled workforce, resulting in a gap between the technological potential and the real-world implementation. To address this deficiency, public-private collaborations and educational initiatives are being established. Furthermore, supported by government funding and venture capital interest, India's genomics-enabled healthcare startup ecosystem is still growing at a breakneck pace. The growing acceptance of genomics into mainstream healthcare is reflected in this changing landscape.

According to the research report, ""India Genomic Market Overview, 2030,"" published by Bonafide Research, the India Genomic market is anticipated to add to more than USD 1.63 Billion by 2025–30. Due to rising health awareness, technological progress, and strategic government programs, the Indian genomics market is experiencing tremendous expansion, with a strong CAGR projected for the next several years. Recent estimates place the market's worth in the hundreds of millions of dollars, and forecasts point to ongoing double-digit growth over the next ten years. The ambitious national Genome India Project (GIP) by the Indian government, which seeks to sequence the genomes of 10,000 different Indian citizens, is a key driver of this expansion. The goal of this project is to establish a local reference database that will enable precision medicine that is customized to India's specific genetic composition. The advent of inexpensive genetic testing kits for use at home has been one of the market's most revolutionary changes. By allowing people to readily test for predispositions to lifestyle diseases, carrier status for inherited diseases, and even customized nutrition and fitness plans, these kits have democratized access to genomics. Businesses like Mapmygenome and MedGenome are leading the way, providing a variety of services, including disease risk profiling and genomic evaluations pertaining to health. The main users of these preventative genetic tests are India's middle- and high-income city dwellers. As a result of greater health awareness, particularly in the wake of the COVID pandemic, there is an increase in demand for preventative healthcare options, and genetic testing is currently seen as a proactive step in identifying diseases early on and developing individualized wellness plans. Furthermore, India's genomics sector is seeing innovation and capacity development driven by partnerships with international genomics businesses and venture capital investments. Nevertheless, there are still obstacles, such as the requirement for consistent data privacy procedures and regulatory clarity. The trend towards customized healthcare in India is indicated by the growth of the market for preventative genetic testing, particularly in metropolitan regions such as Mumbai, Delhi, and Bengaluru.

The genomics market by product is divided into ""Products"" and ""Services”. Among the product categories are genomic consumables such as DNA extraction kits, library preparation kits, sequencing reagents, bioinformatics software, and hardware platforms for sequencing and analysis. These products are crucial for performing genomic sequencing, gene expression research, and variant analysis. Some of the top firms offering genomic goods in India include Illumina (through partnerships), Xcode Life, Mapmygenome, and MedGenome. These players are involved in offering genomic research tools, software solutions, and testing services. Next-Generation Sequencing (NGS), PCR (Polymerase Chain Reaction), and CRISPR gene editing are examples of cutting-edge technologies that are fueling the rise in demand for products. In particular, NGS has transformed the cost and pace of sequencing, making genomics more accessible to research labs and clinical environments throughout India. These genomic products have a wide range of uses, including clinical diagnostics (particularly in oncology and rare diseases), pharmacogenomics, agricultural genomics, and population genetics research. The primary users of genomic products in India include diagnostic laboratories, hospitals, pharmaceutical businesses, universities, and research institutes. In particular, in the fields of cardiology and oncology, urban healthcare professionals are increasingly incorporating genomic testing into customized treatment programs. Indian businesses provide a range of services, including prenatal testing, carrier screening, exome sequencing, entire genome sequencing, genetic counseling, and ancestry services. Neuberg Diagnostics, Mapmygenome, MedGenome, and Strand Life Sciences are a few of the top service providers. Genomic services in India are used in a variety of fields, including clinical diagnostics, drug discovery, agricultural biotechnology, personalized medicine, and ancestry analysis. The genomics industry in India is well-positioned for continued expansion, driven by growing demand from both research and healthcare, and backed by both private innovation and government-backed programs like the Genome India Project.

A variety of technologies drive the Indian genomics industry, and each one makes a unique contribution to the nation's expanding biomedical and research environment. The cornerstone technology is now Next-Generation Sequencing (NGS), which allows for the quick and affordable sequencing of whole genomes, exomes, or specific sections. NGS platforms are widely used in both clinical diagnostics particularly for oncology, rare diseases, and infectious disease detection and research applications. Its usage in customized healthcare in India has been made popular by firms like Mapmygenome and MedGenome. Still widely used in mutation analysis and gene amplification, the polymerase chain reaction (PCR) is a basic technology. Routine diagnostic laboratories continue to rely heavily on PCR, particularly for detecting infectious illnesses such tuberculosis and COVID-19, as well as for genetic testing in reproductive healthcare. The primary application of microarrays is in determining SNP (single nucleotide polymorphism) and gene expression profiles. Microarrays continue to be useful in pharmacogenomic applications and big-scale population studies because of their cost-effectiveness for particular kinds of analysis, even if their use is slowly being replaced by NGS. Even if it is older, Sanger Sequencing is still the gold standard for confirming the findings of high-throughput approaches, particularly in clinical diagnostics for identifying certain mutations or in small-scale investigations. Due to its ability to examine gene expression at the single-cell level, flow cytometry is widely used in genomics-related cellular studies, particularly in immunology and cancer research. For leukemia diagnosis and immunotherapy research, flow cytometry is used in hospitals and research facilities to combine genomic knowledge with cell surface marker analysis. Other developing technologies include bioinformatics platforms, which manage large genomic datasets, and CRISPR gene editing tools, which are used in functional genomics research. These technologies have revolutionized genomics in India, enabling cutting-edge research, clinical breakthroughs, and the increasing implementation of precision medicine throughout the nation's healthcare system.

Diagnostics, particularly in oncology, is one of the most important fields of application. Genomic profiling of tumors in this area allows for tailored cancer treatment regimens based on individual genetic mutations. Another developing field is cardiology, where genomics helps in detecting inherited heart conditions and enhancing preventative treatment. Genomic sequencing has greatly aided in the diagnosis of rare diseases, providing answers for patients with unknown genetic conditions. Genomic methods are also used in infectious diseases, especially tuberculosis and viral infections, to speed up and improve the accuracy of pathogen identification and drug resistance profiling. Drug discovery and development is another critical area where genomics improves the identification of new drug targets, comprehension of disease pathways, and prediction of drug responses. Genomic discoveries are being used more and more by Indian research institutions and pharmaceutical businesses to cut time and costs in drug development pipelines. In India, genomics-driven healthcare is based on the principles of precision medicine. Precision medicine improves treatment effectiveness, lowers adverse drug responses, and promotes preventative care approaches by customizing medical therapies to a person's genetic profile, notably in the fields of metabolic diseases, oncology, and rare genetic illnesses. Programs like the Genome India Project are promoting this strategy into mainstream healthcare. In the fields of agriculture and animal genomics, genomic methods are transforming crop improvement, livestock breeding, and disease resistance programs. Genomic markers are being used by research establishments throughout India to create drought-resistant, high-yielding crop kinds, which helps ensure food security. Applications include forensics, in which genomic methods assist in criminal investigations and paternity testing, as well as nutrigenomics, which examines the interaction between diet and genes in order to provide individualized dietary programs. India's use of genomics is revolutionizing industries and providing answers that are specific to the nation's specific population and healthcare issues in the domains of clinical, research, agriculture, and lifestyle.

Considered in this report
• Historic Year: 2019
• Base year: 2024
• Estimated year: 2025
• Forecast year: 2030

Aspects covered in this report
• Genomic Market with its value and forecast along with its segments
• Various drivers and challenges
• On-going trends and developments
• Top profiled companies
• Strategic recommendation

By Product & Services
• Products
• Services

By Technology
• Next-Generation Sequencing (NGS)
• PCR
• Microarrays
• Sanger Sequencing
• Flow Cytometry
• Others

By Application
• Diagnostics (Oncology, Cardiology, Rare Diseases, Infectious Diseases, Others)
• Drug Discovery and Development
• Precision Medicine
• Agriculture & Animal Genomics
• Other Applications